| Home > Publications Database > Neuroprotection and Neuroregeneration Strategies for Neurodegenerative Diseases > print |
| 001 | 144649 | ||
| 005 | 20220601113748.0 | ||
| 024 | 7 | _ | |2 doi |a 10.1201/b14584-25 |
| 037 | _ | _ | |a DZNE-2020-00161 |
| 100 | 1 | _ | |a De Bartolo, Loredana |b 0 |e Editor |
| 245 | _ | _ | |a Neuroprotection and Neuroregeneration Strategies for Neurodegenerative Diseases |
| 260 | _ | _ | |b CRC Press |c 2013 |
| 295 | 1 | 0 | |a Biomaterials for Stem Cell Therapy / De Bartolo, Loredana (Editor) ; : CRC Press, 2013, ; ISBN: 978-1-4665-7639-1 ; doi:10.1201/b14584 |
| 300 | _ | _ | |a 495 - 537 |
| 336 | 7 | _ | |2 ORCID |a BOOK_CHAPTER |
| 336 | 7 | _ | |0 7 |2 EndNote |a Book Section |
| 336 | 7 | _ | |2 DRIVER |a bookPart |
| 336 | 7 | _ | |2 BibTeX |a INBOOK |
| 336 | 7 | _ | |2 DataCite |a Output Types/Book chapter |
| 336 | 7 | _ | |0 PUB:(DE-HGF)7 |2 PUB:(DE-HGF) |a Contribution to a book |b contb |m contb |s 1654076064_17984 |
| 520 | _ | _ | |a Acute and chronic neurodegenerative diseases of the central nervous system (CNS) are among the major challenges faced by neuroscientifi c research, by the pharmaceutical industry and by healthcare systems in most, if not all, industrialized countries. This situation is a consequence of our present inadequate understanding of the molecular and cellular mechanisms of neurodegeneration, and it has resulted in a lack of diagnostic resources and therapeutic options as well as in the need for long-term and costly nursing of patients. Many CNS diseases are correlated with age, and thus-following present-day world-wide demographic trends-they are becoming even more important. Consequently, better strategies to prevent, diagnose and/or treat diseases such as stroke and cerebral ischemia, Parkinson’s disease, German Center for Neurodegenerative Diseases (DZNE), AG Neurodegeneration and Intervention Strategies, c/o Universitätsklinikum, Leipziger Str. 44, D-39120 Magdeburg, Germany. Email: frank.striggow@dzne.de multiple sclerosis, Alzheimer’s disease and other forms of dementia are urgently needed. © 2013 by Taylor and Francis Group, LLC. |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-342 |a 342 - Disease Mechanisms and Model Systems (POF3-342) |c POF3-342 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef Book |
| 700 | 1 | _ | |a Bader, Augustinus |b 1 |e Editor |
| 700 | 1 | _ | |0 P:(DE-2719)9000420 |a Striggow, Frank |b 2 |e Corresponding author |u dzne |
| 773 | _ | _ | |a 10.1201/b14584-25 |
| 856 | 4 | _ | |u 10.1201/b14584-25 |
| 909 | C | O | |o oai:pub.dzne.de:144649 |p VDB |
| 910 | 1 | _ | |0 I:(DE-588)1065079516 |6 P:(DE-2719)9000420 |a Deutsches Zentrum für Neurodegenerative Erkrankungen |b 2 |k DZNE |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-342 |1 G:(DE-HGF)POF3-340 |2 G:(DE-HGF)POF3-300 |3 G:(DE-HGF)POF3 |4 G:(DE-HGF)POF |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |v Disease Mechanisms and Model Systems |x 0 |
| 914 | 1 | _ | |y 2013 |
| 920 | 1 | _ | |0 I:(DE-2719)5000045 |k AG Striggow |l Neurodegeneration and intervention strategies |x 0 |
| 980 | _ | _ | |a contb |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)5000045 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|